No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Tekni-Plex Acquires Johnson Plastic Group

Expands Medical Device Footprint

Editor: What To Know

  •   We now will be able to provide even greater opportunities for our employees and a broader range of products and material science solutions for our customers.
  • “It builds upon our existing solutions capabilities and increases our geographic reach, bringing us close to our key customer base in Mexico and the Baja region.
  • Tekni-Plex Healthcare has acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform.

Tekni-Plex Healthcare has acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform.

Located in Mexicali, Mexico, Johnson Plastic Group specializes in precision extrusions for medical device applications. The company provides complete extrusion solutions into a variety of medical device applications for interventional and therapeutic procedures.

The acquisition expands Tekni-Plex Healthcare’s medical device capabilities and broadens the division’s global footprint by adding a presence in Mexico.

“This acquisition makes total sense for us and improves our ability to service our customers,” said Chris Qualters, CEO of Tekni-Plex Healthcare. “It builds upon our existing solutions capabilities and increases our geographic reach, bringing us close to our key customer base in Mexico and the Baja region. It also allows us to leverage JPG’s expertise across our entire global customer base and healthcare end markets.”

Qualters noted: “The addition of JPG continues to build upon our innovative patient care solutions platform centered on material science and process technologies. We are looking forward to creating an even more robust set of offerings and solutions that help improve patient outcomes.”

Enrique Preciado, JPG owner and general manager, said: “We are truly excited to become part of Tekni-Plex Healthcare.  We now will be able to provide even greater opportunities for our employees and a broader range of products and material science solutions for our customers.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy